Synthesis, characterization, and cytotoxicity of a novel highly charged trinuclear platinum compound. Enhancement of cellular uptake with charge

Inorganic Chemistry

Volumn 44, Issue 26, 2005, Pages 9598-9600

  Harris, Amanda L ^a   Yang, Xiaohong ^a   Hegmans, Alex ^a   Povirk, Lawrence ^a   Ryan, John J ^a   Kelland, Lloyd ^b   Farrell, Nicholas P ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLATINUM DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; SYNTHESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; MOLECULAR STRUCTURE; PLATINUM COMPOUNDS;

EID: 31044449467     PISSN: 00201669     EISSN: None     Source Type: Journal    
DOI: 10.1021/ic051390z     Document Type: Article

References (23)

1. Farrell, N. Met. Ions Biol. Syst. 2004, 42, 251-296.
2. Manzotti, C.; Pratesi, G.; Menta, E.; Di Domenico, R.; Fiebig, H. H.; Kelland, L. R.; Farrell, N.; Polizzi, D.; Supino, R.; Pezzoni, G.; Zunino, F. Clin. Cancer Res. 2000, 6, 2626-2634.
3. Farrell, N. P. Semin. Oncol. 2004, 31, 1-9.
4. Hegmans, A.; Berners-Price, S. J.; Davies, M. S.; Thomas, D. S.; Humphreys, A. S.; Farrell, N. J. Am. Chem. Soc. 2004, 126, 2166-2180.
5. Kasparkova, J.; Zehnulova, J.; Farrell, N.; Brabec, V. J. Biol. Chem. 2002, 277, 48076-48086.
6. Qu, Y.; Scarsdale, N. J.; Tran, M.; Farrell, N. P. J. Biol. Inorg. Chem. 2003, 8, 19-28.
7. Qu, Y.; Harris, A.; Hegmans, A.; Kabolizadeh, P.; Penazova, H.; Farrell, N. J. Inorg. Biochem. 2004, 98, 1591-1598.
8. Harris, A.; Qu, Y.; Farrell, N. P. Inorg. Chem. 2005, 44, 1196-1198.
9. Da Re, G.; Di Domenico, R.; Spinelli, S.; Farrell, N. U.S. Patent 6,313,333, 2001.
10. 1H NMR δ 3.00 (t), 2.67 (m), 1.65 (m), 1.38 (m) ppm; HPLC purity 97%. Elem Anal. Found (calcd): C, 16.84 (16.91); H, 5.12 (5.32); N, 17.93 (18.08).
11. Fojo, T.; Farrell, N.; Ortuzar, W.; Tanimura, H.; Weinstein, J.; Myers, T. G. Crit. Rev. Oncol./Hematol. 2005, 53, 25-34.
12. Farrell, N. Polynuclear Charged Platinum Compounds as a New Class of Anticancer Agents. Toward a New Paradigm. In Platinum-Based Drugs in Cancer Therapy; Kelland, L. R., Farrell, N., Eds.; Humana Press: Totowa, NJ, 2000; pp 321-338.
13. Hills, C. A.; Kelland, L. R.; Abel, G.; Siracky, J.; Wilson, A. P.; Harrap, K. R. Br. J. Cancer 1989, 59, 527-534.
14. Oehlsen, M.; Qu, Y.; Farrell, N. Inorg. Chem. 2003, 42, 5498-5506.
15. Jansen, B. A.; Brouwer, J.; Reedijk, J. J. Inorg. Biochem. 2002, 89, 197-202.
16. Collins, J. G.; Wheate, N. J. J. Inorg. Biochem. 2004, 98, 1578-1584 and references cited therein.
17. 2 cocrystallized with multinuclear platinum(II) complexes: Noncovalent interactions between DNA and potential anticancer drugs. Poster Presentation at European Biological Inorganic Chemistry Conference, Garmisch-Partenkirchen, Germany, 2004.
18. Harris, A.; Qu, Y.; Yang, X.; Povirk, L.; Farrell, N. Unpublished results, 2005.
19. Harris, A. Dissertation, Virginia Commonwealth University, Richmond, VA, 2005.
20. Wang, P.; Bauer, G.; Bennet, R.; Povirk, L. Biochemistry 1991, 30, 11515-11521.
21. Wheate, N. J.; Webster, L. K.; Brodie, C. R.; Collins, J. G. Anti-Cancer Drug Des. 2000, 15, 313-322.
22. Martins, E. T.; Baruah, H.; Kramarczyk, J.; Saluta, G.; Day, C. S.; Kucera, G. L.; Bierbach, U. J. Med. Chem. 2001, 44, 4492-4496.
23. Burckhardt, G. Mol. Pharmacol. 2005, 67, 1391-1392.